203 related articles for article (PubMed ID: 22333004)
1. Current controversies in the use of haemoglobin A1c.
Hare MJ; Shaw JE; Zimmet PZ
J Intern Med; 2012 Mar; 271(3):227-36. PubMed ID: 22333004
[TBL] [Abstract][Full Text] [Related]
2. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus.
Mostafa SA; Davies MJ; Webb D; Gray LJ; Srinivasan BT; Jarvis J; Khunti K
Diabet Med; 2010 Jul; 27(7):762-9. PubMed ID: 20636956
[TBL] [Abstract][Full Text] [Related]
3. Hba(1c) as a tool for the diagnosis of type 2 diabetes: comparison with fasting glucose.
Tatsch E; Bochi GV; Piva SJ; Pereira RS; Kober H; De Carvalho JA; Sangoi MB; Duarte MM; Moresco RN
Clin Lab; 2012; 58(3-4):347-50. PubMed ID: 22582512
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
Gołembiewska E
Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
[TBL] [Abstract][Full Text] [Related]
5. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.
Bennett CM; Guo M; Dharmage SC
Diabet Med; 2007 Apr; 24(4):333-43. PubMed ID: 17367307
[TBL] [Abstract][Full Text] [Related]
6. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
[TBL] [Abstract][Full Text] [Related]
7. Glycated haemoglobin or mean blood glucose as indicators of metabolic control in Type 2 diabetes?
Pupillo M; De Berardis G; Antenucci D; Minnucci A; Nicolucci A
Diabetes Res Clin Pract; 2008 Jun; 80(3):e1-3. PubMed ID: 18258329
[TBL] [Abstract][Full Text] [Related]
8. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
[TBL] [Abstract][Full Text] [Related]
9. Haemoglobin A1c is not a surrogate for glucose and insulin measures for investigating the early life and childhood determinants of insulin resistance and Type 2 diabetes in healthy children. An analysis from the Avon Longitudinal Study of Parents and Children (ALSPAC).
Shultis WA; Leary SD; Ness AR; Scott J; Martin RM; Whincup PH; Smith GD;
Diabet Med; 2006 Dec; 23(12):1357-63. PubMed ID: 17116188
[TBL] [Abstract][Full Text] [Related]
10. Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony.
Berg AH; Sacks DB
J Clin Pathol; 2008 Sep; 61(9):983-7. PubMed ID: 18755722
[TBL] [Abstract][Full Text] [Related]
11. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
Borg R; Vistisen D; Witte DR; Borch-Johnsen K
Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic testing for diabetes using HbA(1c) in the Abu Dhabi population: Weqaya: the Abu Dhabi cardiovascular screening program.
Hajat C; Harrison O; Al Siksek Z
Diabetes Care; 2011 Nov; 34(11):2400-2. PubMed ID: 21926284
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
[TBL] [Abstract][Full Text] [Related]
14. HbA(1c) measurement for the diagnosis of diabetes: is it enough?
Cavagnolli G; Comerlato J; Comerlato C; Renz PB; Gross JL; Camargo JL
Diabet Med; 2011 Jan; 28(1):31-5. PubMed ID: 21210540
[TBL] [Abstract][Full Text] [Related]
15. HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.
Bhowmik B; Diep LM; Munir SB; Rahman M; Wright E; Mahmood S; Afsana F; Ahmed T; Khan AK; Hussain A
Diabet Med; 2013 Mar; 30(3):e70-7. PubMed ID: 23199158
[TBL] [Abstract][Full Text] [Related]
16. Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
Jeffcoate SL
Diabet Med; 2004 Jul; 21(7):657-65. PubMed ID: 15209755
[TBL] [Abstract][Full Text] [Related]
17. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
[TBL] [Abstract][Full Text] [Related]
19. What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006?
Cosson E; Nguyen MT; Hamo-Tchatchouang E; Banu I; Chiheb S; Charnaux N; Valensi P
Diabet Med; 2011 May; 28(5):567-74. PubMed ID: 21480967
[TBL] [Abstract][Full Text] [Related]
20. [Glycated haemoglobin may in future be reported as estimated mean blood glucose concentration--secondary publication].
Borg R; Nerup J; Nathan DM; Kuenen J; Zheng H; Schoenfeld D; Heine RJ;
Ugeskr Laeger; 2009 Nov; 171(45):3262-5. PubMed ID: 19916193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
